Feasibility, Safety & Diagnostic Input of Interventional Cardiac MRI on a

See also
Status	Clinical Trial	Phase
Completed	`NCT03031587` - Validation of Thermometric Cardiac Imaging by MRI	N/A
Completed	`NCT03661827` - Dobutamine vs Adenosine CMR Study	N/A
Completed	`NCT02655770` - Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients	Phase 4
Active, not recruiting	`NCT04967807` - Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study)	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT03031587 - Validation of Thermometric Cardiac Imaging by MRI

N/A

Completed

NCT03661827 - Dobutamine vs Adenosine CMR Study

N/A

Completed

NCT02655770 - Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients

Phase 4

Active, not recruiting

NCT04967807 - Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study)

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05103852
Study type	Interventional
Source	Ramsay Générale de Santé
Contact	Jean-François Oudet
Phone	0683346567
Email	jf.oudet@ecten.eu
Status	Recruiting
Phase	N/A
Start date	December 13, 2018
Completion date	December 13, 2021

Feasibility, Safety and Diagnostic Input of Interventional Cardiac MRI on a Series of 35 Patients With an Indication of Right Cardiac Catheterization. — IRM Cardiaque

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms